Q32 Bio (QTTB) News
NASDAQ: QTTBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.34-0.14 (-1.65%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
QTTB news summary
We found 2 recent headlines mentioning Q32 Bio (QTTB): 0 in the past week and 1 in the past 30 days, most often from PR Newswire, Nasdaq. For price context, QTTB is down 1.65% at $8.34. The most recent story, "Q32 Bio to Participate in the 2026 Jefferies Global Healthcare Conference in London", was published by PR Newswire on Nov 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Q32 Bio headlines
- Q32 Bio to Participate in the 2026 Jefferies Global Healthcare Conference in LondonWALTHAM, Mass., Nov. 11, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical-stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and…PR Newswire
- Leerink Partners Initiates Coverage of Q32 Bio with OutperformFintel reports that on October 12, 2026, Leerink Partners initiated coverage of Q32 Bio (NASDAQCM:QTTB) (DB:DB0) with a Outperform recommendation.Prior to this rating action, the stock closed at…Nasdaq